BackBlossomHill Therapeutics Overview

BlossomHill Therapeutics Net Tangible Assets

Track BlossomHill Therapeutics's net tangible assets ($82M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$82.04M

Peer trimmed avg / median

Loading

BlossomHill Therapeutics Net Tangible Assets History

Loading

BlossomHill Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

BlossomHill Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BlossomHill Therapeutics (BLSM) FAQ

As of the most recent data (June 2026), BLSM shows a net tangible assets of $82M. Scroll down for historical charts and peer comparison views.

Tracking BLSM's net tangible assets over time shows whether BlossomHill Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $82M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has BlossomHill Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $82M) with ownership activity and broader fundamentals.

BlossomHill Therapeutics's net tangible assets is $82M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.